BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Jan 17, 2011
 |  BC Week In Review  |  Clinical News  |  Regulatory

Daxas roflumilast regulatory update

The Global Initiative for Chronic Obstructive Lung Disease (GOLD) released updated chronic obstructive pulmonary disease (COPD) management guidelines that include Nycomed's Daxas roflumilast as a treatment option for COPD. The oral ...

Read the full 137 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >